MDLinx September 19, 2024
Key Takeaways
GLP-1 receptor agonists like Ozempic show promise not only in treating type 2 diabetes and obesity but also in potentially addressing other health issues, such as addiction and cognitive decline.
While GLP-1s represent a revolutionary advancement in treatment, barriers such as insurance coverage and access still exist.
There is a...